Outcomes of Post-operative Diet in Children Following Tonsillectomy and Adenoidectomy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03437954 |
|
Recruitment Status : Unknown
Verified March 2019 by Georgetown University.
Recruitment status was: Recruiting
First Posted : February 19, 2018
Last Update Posted : March 12, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Chronic Tonsillitis Sleep Disordered Breathing | Other: Diet modification | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 86 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Care Provider, Outcomes Assessor) |
| Primary Purpose: | Other |
| Official Title: | Outcomes of Post-operative Diet in Children Following Tonsillectomy and Adenoidectomy |
| Actual Study Start Date : | December 15, 2017 |
| Estimated Primary Completion Date : | December 31, 2019 |
| Estimated Study Completion Date : | December 31, 2019 |
| Arm | Intervention/treatment |
|---|---|
| Standard soft diet |
Other: Diet modification
Patients will be randomized to follow the standard post-tonsillectomy diet at our institution, which consists of soft foods for ten days, or will be in the non-restricted diet group following surgery. |
| Non-restricted diet |
Other: Diet modification
Patients will be randomized to follow the standard post-tonsillectomy diet at our institution, which consists of soft foods for ten days, or will be in the non-restricted diet group following surgery. |
- Bleeding [ Time Frame: From time of surgery through postoperative day 10. ]Blood tinged sputum or hemoptysis reported by patient or patient caregiver to on call resident or at post operative appointment; blood clot or bleeding from tonsil bed observed objectively on physical examination.
- Pain [ Time Frame: From time of surgery through postoperative day 10. ]Patient or patient caregiver report of pain at each post operative day using a validated Wong Baker FACES pain scale.
- Days missed from normal activity [ Time Frame: From time of surgery through postoperative day 10. ]Patient or patient care giver reported number of days spent absent from normal activity as noted at post operative visit.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 3 Years to 12 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients 3-12 years undergoing tonsillectomy and/or adenoidectomy.
Exclusion Criteria:
-
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03437954
| Contact: Kelly Scriven, MD | 202-444-8186 | kelly.a.scriven@gmail.com | |
| Contact: Earl Harley, MD | 202-444-8186 | harleye@georgetown.edu |
| United States, District of Columbia | |
| MedStar Georgetown University Hospital | Recruiting |
| Washington, District of Columbia, United States, 20007 | |
| Contact: Earl Harley, MD 202-444-8186 harleye@georgetown.edu | |
| Study Director: | Earl Harley, MD | MedStar Georgetown University Hospital |
| Responsible Party: | Georgetown University |
| ClinicalTrials.gov Identifier: | NCT03437954 |
| Other Study ID Numbers: |
Georgetown_Univeristy_MC |
| First Posted: | February 19, 2018 Key Record Dates |
| Last Update Posted: | March 12, 2019 |
| Last Verified: | March 2019 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Tonsillitis Sleep Apnea Syndromes Respiration Disorders Respiratory Tract Diseases Apnea Sleep Disorders, Intrinsic Dyssomnias Sleep Wake Disorders |
Nervous System Diseases Pharyngitis Respiratory Tract Infections Infections Pharyngeal Diseases Stomatognathic Diseases Otorhinolaryngologic Diseases |

